Join to access to all OVN content. Join for Free
The ART of Excellence... How to be a Rock Star MSL
medical affairs industry writing process adaptability resilience MSLs

The ART of Excellence... How to be a Rock Star MSL


Share This Article


Summary

In this episode, Cathy Andorfer joins Tom Caravela to discuss her new book and the journey of writing it. Cathy shares insights into her writing process, addressing challenges and the evolving landscape of the medical affairs industry. The conversation highlights the significance of adaptability and resilience for MSLs, along with maintaining a positive mindset amidst industry changes. Cathy reflects on the importance of these traits in her career and provides a glimpse into future industry trends. The episode wraps up with expressions of gratitude and a reminder about the upcoming Mass West event, followed by credits and sponsor information.

In this week’s episode, Cathy Andorfer, National MSL Director shares The ART of Excellence…How to become a Rock Star MSL

Click for Source
medical affairs industry, writing process, adaptability, resilience, MSLs

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Healthy on the Road-How to Avoid MSL Belly
Partner Avatar MSL Talk: Tom Caravela, Alex Palumbo

Healthy on the Road-How to Avoid MSL Belly

Podcast
The Strategic vs the Scientific MSL
Partner Avatar MSL Talk: Tom Caravela, Joy Morrell

The Strategic vs the Scientific MSL

Article
Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions
OVN Avatar Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH

Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions

Article
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
OVN Avatar Emmanuelle Jacqueta, Ghania Kerouani-Lafayeb, Francoise Grudeb, Sergio Goncalvesb, Annie Lorenced, Florence Turcryb, Liora Brunelb, Laetitia Belgodereb, Adrien Monardc, Gaëlle Guyaderb, Lotfi Boudalib, Nicolas Albin

Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years

Article
Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review
OVN Avatar Aaron S. Long, BS; Audrey D. Zhang, MD; Caitlin E. Meyer, MLIS; Alexander C. Egilman, BS; Joseph S. Ross, MD, MHS; Joshua D. Wallach, PhD, MS

Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review

Article
Transforming oncology: Five frontiers driving progress in cancer care
Partner Avatar iNIZIO

Transforming oncology: Five frontiers driving progress in cancer care

Explore OVN